Payers could be aggressive in trying to drive down prices of new anti-PCSK9 cholesterol drugs, according to a survey of recent comments by RBC Capital Markets. On the other hand, fears of losing money from hepatitis C drugs seem to be fading as U.S. prescriptions are falling off. Analyst Michael Yee rounded up comments from the major health insurers and pharmacy benefit managers on their Q2 earnings calls in a report issued Thursday. After last
More companies are giving website visitors a solution to password fatigue. Businesses are letting people access their websites by using the logins from their Facebook (FB), Twitter (TWTR) or other sites — a kind of universal sign-in mechanism for websites and apps that employs a one-click login icon linked to the user’s social media account. Facebook, Twitter and other social media sites often then share what personal information they know about
Networking leader Cisco Systems late Wednesday put a kicker on the end of Chief Executive John Chambers’ era with an earnings and revenue beat, which was typical of the firm under Chambers’ 20-year reign. Cisco (CSCO) said that earnings minus items for its fiscal Q4, which ended July 25, rose 7.3% from the year-earlier quarter to 59 cents, ahead of the 56-cent consensus forecast of analysts polled by Thomson Reuters. Revenue rose 3.9% to $12.8